This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Mergers, Casualty Losses Drive U.S. Insurers: 4 Picks
by Nitish Marwah
A series of natural disasters, an aging American population and increased number of vehicles on the roads have led to an increase in prices of insurance premiums.
Here's Why Momentum Investors Will Love Cigna (CI)
by Zacks Equity Research
Does Cigna (CI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Top Ranked Momentum Stocks to Buy for November 8th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 8th
Zacks.com highlights: BioTelemetry, Ericsson, Intel, United States Cellular and Cigna
by Zacks Equity Research
Zacks.com highlights: BioTelemetry, Ericsson, Intel, United States Cellular and Cigna
5 Relative Price Strength Stocks to Maximize Your Returns
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
The Zacks Analyst Blog Highlights: Verizon, Express Scripts, Cigna, Ecolab and eBay
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Verizon, Express Scripts, Cigna, Ecolab and eBay
Is Cigna (CI) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (CI) Outperforming Other Finance Stocks This Year?
New Strong Buy Stocks for November 2nd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Top Stock Reports for Verizon, Express Scripts & Cigna
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Verizon (VZ), Express Scripts (ESRX), and Cigna (CI).
Cigna (CI) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 11.30% and 2.02%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) Q3 Earnings & Revenues Beat, Guidance Up
by Zacks Equity Research
Cigna (CI) Q3 earnings gain on revenue and membership growth.
Insurers Set to Report Q3 Earnings on Nov 1: CI, MET, LNC, Y
by Zacks Equity Research
Insurers' third-quarter performance is likely to be supported by a favorable operating environment, although catastrophe loss can be a drag.
Why Cigna (CI) Might Surprise This Earnings Season
by Zacks Equity Research
Cigna (CI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Will Cigna (CI) Q3 Earnings Gain on Revenue Growth?
by Zacks Equity Research
Cigna (CI) Q3 earnings should gain from revenue and membership growth
Cigna (CI) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $206.69, marking a -1.75% move from the previous day.
Will Stronger Premiums Drive Everest Re (RE) Q3 Earnings?
by Zacks Equity Research
Everest Re Group's (RE) third-quarter results are likely to benefit from better results at both insurance and Reinsurance segments.
Cigna (CI) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cigna (CI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Cigna (CI) closed at $212.73 in the latest trading session, marking a +0.72% move from the prior day.
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FTCS
Will Optum Aid UnitedHealth Group's (UNH) Q3 Earnings?
by Zacks Equity Research
Revenue and earnings gains across all the Optum's subsegments should aid UnitedHealth's Q3 earnings.
Cigna (CI) Stock Moves -1.89%: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $209.99, marking a -1.89% move from the previous day.
Intercontinental Closes MERS Buyout, Boosts Service Offering
by Zacks Equity Research
Intercontinental's (ICE) acquisition of MERS will enable it offer better customer service as the U.S. mortgage finance industry is gradually shifting to more digital mortgages and electronic notes.
CNO Financial's Ratings Upgraded by Moody's, Outlook Stable
by Zacks Equity Research
Moody's lifts the ratings of CNO Financial (CNO). The outlook for the ratings remains stable.
Zacks.com highlights: Cigna, Celanese, Teradyne, CBRE Group and EMCOR Group
by Zacks Equity Research
Zacks.com highlights: Cigna, Celanese, Teradyne, CBRE Group and EMCOR Group
5 GARP Stocks for a Winning Portfolio
by Zacks Equity Research
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.